Oscar Huang

Oscar Huang

Company: Lyterian Therapeutics

Job title: Associate Director, Biophysics


Panel Discussion: Addressing Current Challenges in Ligand Screening & Strategizing the Next- Generation of Discovery Platforms to Overcome Data & Capacity Constrains 9:30 am

How to face ligand screening in the absence of an active construct after purification? What are the next generation of ligand discovery platforms? Biochemical versus cell-based assays What challenges do we need to overcome to de-risk these? Should we pursue covalent or non-covalent interactors?Read more

day: Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.